filmov
tv
Coronavirus: Moderna reports early signs of progress during phase 1 of vaccine trial
Показать описание
Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday. CNBC's Meg Tirrell reports.
For more coronavirus live updates:
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
For more coronavirus live updates:
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
Coronavirus: Moderna reports early signs of progress during phase 1 of vaccine trial
Moderna reports positive data on early-stage coronavirus vaccine trial, shares surge
Moderna’s Coronavirus Vaccine Shows Signs of Early Progress
Moderna reports positive early vaccine trial results
Moderna Coronavirus Vaccine Is Showing Early Promise | TODAY
Early data on Moderna's COVID-19 vaccine insufficient: Report
Moderna Announces ‘Encouraging’ Coronavirus Vaccine Trial Results
Moderna Reports Phase 1 Success In Coronavirus Vaccine Tests
Moderna's COVID-19 vaccine shows early promise
Moderna reports encouraging results from Phase 1 of COVID-19 vaccine trial
Moderna reports encouraging results from Phase 1 of COVID-19 vaccine trial
Promising Coronavirus Vaccine Data From Moderna Therapeutics
Moderna reports new COVID-19 vaccine to be effective against BA.2.86 | NewsNation Live
Moderna COVID-19 Vaccine Early Results Promising – When Can Public Get It?
Moderna and Pfizer request the FDA to clear COVID-19 vaccine for ages 12-17 for emergency use
Rising Crisis Update: Moderna reports promising vaccine trial, Disney to open part of Orlando resort
Ask Dr. Nandi: Moderna’s coronavirus vaccine shows encouraging early results in human safety trial
MIT Professor’s Moderna Stake on Brink of Topping $1 Billion
Moderna releases interim phase one vaccine results
Doubts About Moderna's Virus Vaccine Halts Rally
Local sharemarket continues rise on hope for Moderna's COVID-19 vaccine | Finance Report
Yale professor breaks down Moderna's timeline for a COVID-19 vaccine
Moderna’s COVID Vaccine Shows Promise in Early Trial: Study
Stroke and death after Moderna
Комментарии